BNP Paribas Financial Markets’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $453K | Buy |
15,755
+5,287
| +51% | +$152K | ﹤0.01% | 2616 |
|
|
2025
Q1 | $351K | Sell |
10,468
-4,791
| -31% | -$161K | ﹤0.01% | 2572 |
|
|
2024
Q4 | $780K | Sell |
15,259
-5,683
| -27% | -$291K | ﹤0.01% | 2218 |
|
|
2024
Q3 | $1.07M | Buy |
20,942
+12,000
| +134% | +$613K | ﹤0.01% | 1782 |
|
|
2024
Q2 | $401K | Sell |
8,942
-37,018
| -81% | -$1.66M | ﹤0.01% | 2129 |
|
|
2024
Q1 | $2.15M | Sell |
45,960
-134,535
| -75% | -$6.3M | ﹤0.01% | 1477 |
|
|
2023
Q4 | $6.42M | Sell |
180,495
-123,625
| -41% | -$4.4M | 0.01% | 866 |
|
|
2023
Q3 | $9.04M | Buy |
304,120
+244,960
| +414% | +$7.29M | 0.01% | 647 |
|
|
2023
Q2 | $1.07M | Buy |
59,160
+372
| +0.6% | +$6.7K | ﹤0.01% | 1614 |
|
|
2023
Q1 | $944K | Buy |
58,788
+31,144
| +113% | +$500K | ﹤0.01% | 1795 |
|
|
2022
Q4 | $506K | Sell |
27,644
-17,841
| -39% | -$326K | ﹤0.01% | 1945 |
|
|
2022
Q3 | $893K | Buy |
45,485
+33,443
| +278% | +$657K | ﹤0.01% | 1957 |
|
|
2022
Q2 | $225K | Buy |
12,042
+8,119
| +207% | +$151K | ﹤0.01% | 2411 |
|
|
2022
Q1 | $86.1K | Sell |
3,923
-6,561
| -63% | -$144K | ﹤0.01% | 2834 |
|
|
2021
Q4 | $298K | Buy |
10,484
+3,625
| +53% | +$103K | ﹤0.01% | 2619 |
|
|
2021
Q3 | $144K | Buy |
6,859
+5,387
| +366% | +$113K | ﹤0.01% | 2566 |
|
|
2021
Q2 | $27.7K | Sell |
1,472
-2,169
| -60% | -$40.9K | ﹤0.01% | 2858 |
|
|
2021
Q1 | $55.6K | Sell |
3,641
-2,776
| -43% | -$42.4K | ﹤0.01% | 3018 |
|
|
2020
Q4 | $90.5K | Sell |
6,417
-163
| -2% | -$2.3K | ﹤0.01% | 2614 |
|
|
2020
Q3 | $103K | Buy |
6,580
+5,064
| +334% | +$79.4K | ﹤0.01% | 2484 |
|
|
2020
Q2 | $26.6K | Sell |
1,516
-1,931
| -56% | -$33.8K | ﹤0.01% | 2645 |
|
|
2020
Q1 | $50.7K | Buy |
3,447
+1,823
| +112% | +$26.8K | ﹤0.01% | 2923 |
|
|
2019
Q4 | $40.7K | Buy |
1,624
+56
| +4% | +$1.41K | ﹤0.01% | 3084 |
|
|
2019
Q3 | $23.6K | Buy |
1,568
+546
| +53% | +$8.21K | ﹤0.01% | 3238 |
|
|
2019
Q2 | $25.6K | Sell |
1,022
-826
| -45% | -$20.7K | ﹤0.01% | 3182 |
|
|
2019
Q1 | $42.1K | Buy |
+1,848
| New | +$42.1K | ﹤0.01% | 3012 |
|